Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 6.4.2022Instituto Grifols, S.A. (GFO)45081Flebogamma DIF 50 mg/ml infúzny roztok (sol inf 1x50 ml/2,5 g (liek.skl.))6.4.2022R
 6.4.2022Zentiva a.s. (ZNT-SK-2)49505Losartan Zentiva 100 mg filmom obalené tablety (tbl flm 30x100 mg (blis.PVC/PVDC/Al))6.4.2022O
 6.4.2022Zentiva a.s. (ZNT-SK-2)49507Losartan Zentiva 100 mg filmom obalené tablety (tbl flm 90x100 mg (blis.PVC/PVDC/Al))6.4.2022O
 6.4.2022Zentiva a.s. (ZNT-SK-2)49530Losartan Zentiva 50 mg filmom obalené tablety (tbl flm 90x50 mg (blis.PVC/PVDC/Al))11.4.2022O
 6.4.2022Zentiva, k.s. (ZNT-1)36444Agen 10 (tbl 90x10 mg (blis. PVC/PVDC/Al))11.4.2022O
 6.4.2022Zentiva, k.s. (ZNT-1)7284CLopridam 8 mg/2,5 mg/5 mg (tbl 30x8 mg/2,5 mg/5 mg (blis.OPA/Al/PVC/Al))6.4.2022O
 6.4.2022CSL Behring GmbH (CSL)50935Privigen 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml (liek.inj.skl.))6.4.2022R
 6.4.2022GlaxoSmithKline Trading Services Limited (GAG-IRL-3)2307DNucala 100 mg injekčný roztok naplnený v injekčnej striekačke (sol inj 1x1 ml/100 mg (striek.inj.napl.skl.))25.3.2022O
 6.4.2022Roche Registration GmbH (HLR-DE)44663MIRCERA 250 mikrogramov/0,3 ml injekčný roztok naplnený v injekčnej striekačke (sol inj 1x0,3 ml/250 µg (napl.inj.striek.skl.))1.5.2022Z
 6.4.2022KRKA, d.d., Novo mesto (KRK-2)0697DValtricom 5 mg/160 mg/25 mg filmom obalené tablety (tbl flm 30x5 mg/160 mg/25 mg (blis.OPA/Al/PVC/Al))4.4.2022O
 6.4.2022KRKA, d.d., Novo mesto (KRK-2)3497BArisppa 10 mg tablety (tbl 60x10 mg (blis.OPA/Al/PVC/Al))30.5.2022R
 6.4.2022KRKA, d.d., Novo mesto (KRK-2)4383CBetaklav 500 mg/125 mg filmom obalené tablety (tbl flm 21x500 mg/125 mg (blis.OPA/Al/PVC/Al))9.5.2022R
 5.4.2022Eli Lilly Nederland B.V. (LIL-NL-2)89134Humalog 100 U/ml, injekčný roztok v injekčnej liekovke (sol inj 1x10 ml (liek.inj.skl.))5.4.2022O
 5.4.2022GlaxoSmithKline Consumer Healthcare Czech Republic s.r.o. (GAG-CZ)11847Voltaren Forte 2,32 % gél (gel 1x50 g (tuba LDPE/Al/HDPE so závit.uzáver.))5.4.2022Z
 5.4.2022BB Pharma a.s. (BBP-CZ-1)2194BPENDEPON COMPOSITUM (plv inu 1x1,5 MU (liek.inj.))8.4.2022O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)